BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 16894398)

  • 1. Tacrolimus: focusing on atopic dermatitis.
    Carroll CL; Fleischer AB
    Drugs Today (Barc); 2006 Jul; 42(7):431-9. PubMed ID: 16894398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
    Breuer K; Werfel T; Kapp A
    Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus ointment for the treatment of atopic dermatitis: clinical and pharmacologic effects.
    Rico MJ; Lawrence I
    Allergy Asthma Proc; 2002; 23(3):191-7. PubMed ID: 12125507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials.
    Chen SL; Yan J; Wang FS
    J Dermatolog Treat; 2010 May; 21(3):144-56. PubMed ID: 20394490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An approach to pruritus in atopic dermatitis: a critical systematic review of the tacrolimus ointment literature.
    Fleischer AB; Boguniewicz M
    J Drugs Dermatol; 2010 May; 9(5):488-98. PubMed ID: 20480792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence.
    Kalavala M; Dohil MA
    Am J Clin Dermatol; 2011 Feb; 12(1):15-24. PubMed ID: 21067248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New immune suppressants: topical immunomodulatory agents].
    Senatorski G; Sułowicz W; Paczek L
    Przegl Lek; 2002; 59(11):907-11. PubMed ID: 12715720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pimecrolimus in dermatology: atopic dermatitis and beyond.
    Gisondi P; Ellis CN; Girolomoni G
    Int J Clin Pract; 2005 Aug; 59(8):969-74. PubMed ID: 16033622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
    Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions.
    Simpson D; Noble S
    Drugs; 2005; 65(6):827-58. PubMed ID: 15819596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis.
    Cheer SM; Plosker GL
    Am J Clin Dermatol; 2001; 2(6):389-406. PubMed ID: 11770393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
    Remitz A; Harper J; Rustin M; Goldschmidt WF; Palatsi R; van der Valk PG; Sharpe G; Smith CH; Dobozy A; Turjanmaa K;
    Acta Derm Venereol; 2007; 87(1):54-61. PubMed ID: 17225017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
    Hultsch T; Kapp A; Spergel J
    Dermatology; 2005; 211(2):174-87. PubMed ID: 16088174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pimecrolimus cream and Tacrolimus ointment in the treatment of atopic dermatitis: a pilot study on patient preference.
    Onumah N; Kircik L
    J Drugs Dermatol; 2013 Oct; 12(10):1145-8. PubMed ID: 24085050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis: review of randomised, double-blind clinical studies conducted in Japan.
    Nakagawa H
    Clin Drug Investig; 2006; 26(5):235-46. PubMed ID: 17163257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis.
    Frankel HC; Qureshi AA
    Am J Clin Dermatol; 2012 Apr; 13(2):113-23. PubMed ID: 22263704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids.
    Kirsner RS; Heffernan MP; Antaya R
    Acta Derm Venereol; 2010; 90(1):58-64. PubMed ID: 20107727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus ointment: a new therapy for atopic dermatitis--review of the literature.
    Pustisek N; Lipozencić J; Ljubojević S
    Acta Dermatovenerol Croat; 2002 Mar; 10(1):25-32. PubMed ID: 12137728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis.
    Nghiem P; Pearson G; Langley RG
    J Am Acad Dermatol; 2002 Feb; 46(2):228-41. PubMed ID: 11807435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis.
    El-Batawy MM; Bosseila MA; Mashaly HM; Hafez VS
    J Dermatol Sci; 2009 May; 54(2):76-87. PubMed ID: 19303745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.